VANCOUVER, British Columbia, July 23, 2022 (GLOBE NEWSWIRE) -- Doug Janzen, of 2820 β 200 Granville St., Vancouver, BC, V6C 1S4, today announced that on Tuesday, July 19, 2022, he acquired ownership (the βAcquisitionβ) of 100,000 common shares (βCommon Sharesβ) in the capital of Aequus Pharmaceuticals Inc. (Address: 2820 β 200 Granville St., Vancouver, BC V6C 1S4) (βAequusβ) through the facilities of the TSX Venture Exchange. Mr. Janzen acquired 99,000 Common Shares at a price of $0.07 per Common Share and 1,000 Common Shares at a price of $0.08 per Common Share, for an aggregate purchase price of $7,010.